Please read and agree to the
terms and conditions
of this site.
I agree
Medical Technology
/tech
Clear filters and search
Format
photo
Tags
boston blog main
boston top stories
boulder/denver blog main
boulder/denver top stories
detroit blog main
detroit top stories
fda
3
×
indiana blog main
indiana top stories
life sciences
national
national blog main
national top stories
new york blog main
new york top stories
raleigh-durham blog main
raleigh-durham top stories
regeneron pharmaceuticals
san diego blog main
san diego top stories
san francisco blog main
san francisco top stories
seattle blog main
seattle top stories
texas blog main
texas top stories
wisconsin blog main
wisconsin top stories
biotech
clinical trials
cystic fibrosis
medicare
phrma
sarepta therapeutics
vertex pharmaceuticals
89bio
abbvie
adrian krainer
alex azar
alexion pharmaceuticals
What
drug
prices
3
×
bio
drugs
long
roundup
afternoon
alzheimer’s
annual
anticipated
aren’t
assessed
attention
awaited
biotech
blueprint
communities
conference
cost
cut
details
developers
esmo
europe
fda
gene
germany
help
hosted
house
imminent
investment
lower
meant
medicare
moves
munich
news
noteworthy
patients
Language
Current search:
prices
×
fda
×
@xconomy.com
5 years ago
Bio Roundup: Alzheimer’s Puzzle, ESMO Assessed, Drug Prices & More
@xconomy.com
5 years ago
Bio Roundup: Medicare Drug Prices, FDA Moves, Gene Therapy News & More
@xconomy.com
5 years ago
Trump Pledges Lower Drug Prices, But Blueprint Is Short on Details
